KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Short term Debt (2016 - 2025)

Humana (HUM) has disclosed Short term Debt for 11 consecutive years, with $577.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Short term Debt changed N/A to $577.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $577.0 million, a N/A change, with the full-year FY2022 number at $2.1 billion, up 7.12% from a year prior.
  • Short term Debt was $577.0 million for Q1 2025 at Humana, down from $2.2 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.8 billion in Q3 2022 to a low of $577.0 million in Q1 2025.
  • A 4-year average of $1.7 billion and a median of $1.8 billion in 2022 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: crashed 53.89% in 2021, then skyrocketed 252.08% in 2022.
  • Humana's Short term Debt stood at $2.0 billion in 2021, then grew by 7.12% to $2.1 billion in 2022, then increased by 7.31% to $2.2 billion in 2023, then plummeted by 74.3% to $577.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Short term Debt are $577.0 million (Q1 2025), $2.2 billion (Q3 2023), and $2.0 billion (Q2 2023).